Tissue Factor Pathway Inhibitor Endocytosis

By Schwartz A.L.   Broze G.J.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 7, 1997-10 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite

Regulation of the human tumor necrosis factor- promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors

By Sato H.   Watanabe A.   Tanaka T.   Koitabashi N.   Arai M.   Kurabayashi M.   Yokoyama T.  

Journal of Molecular and Cellular Cardiology, Vol. 35, Iss. 10, 2003-10 ,pp. : 1197-1205

Elsevier

Access to resources Recommend Favorite

Full-length human tissue factor pathway inhibitor inhibits human activated protein C in the presence of heparin

By Hamamoto T.   Kisiel W.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 291-297

Elsevier

Access to resources Recommend Favorite

Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid

By Thyzel E.   Siegling S.   Gotting C.   Tinneberg H.-R.   Brinkmann T.   Kleesiek K.  

Thrombosis Research, Vol. 109, Iss. 5, 2003-03 ,pp. : 329-332

Elsevier

Access to resources Recommend Favorite

RECOMBINANT HUMAN TISSUE FACTOR PATHWAY INHIBITOR AS A POSSIBLE ANTICOAGULANT TARGETING HEPATIC SINUSOIDAL WALLS

By Yamanobe F.   Mochida S.   Ohno A.   Ishikawa K.   Fujiwara K.  

Thrombosis Research, Vol. 85, Iss. 6, 1997-03 ,pp. : 493-501

Elsevier

Access to resources Recommend Favorite